• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NasdaqGM
    0.58 Down 0.02(2.52%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:0.60
    Open:0.59
    Bid:N/A
    Ask:5.55 x 2000
    1y Target Est:9.00
    Beta:0.9
    Next Earnings Date:N/A
    Day's Range:0.58 - 0.60
    52wk Range:0.56 - 4.16
    Volume:105,635
    Avg Vol (3m):239,723
    Market Cap:13.33M
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYCC

    Comparison

    Symbol% ChgMkt Cap
    CYCCDown 2.52%13.33M
    AZNDown 1.18%89.72B
    JNJDown 2.19%280.30B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):7.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.95
    Quarterly EPS Est (Dec-14) :-0.25
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback